Upon closing, R1 RCM begins a 10-year agreement to provide comprehensive RCM services for Providence, according to a Jan. 17 R1 news release.
R1 announced in December that it signed a definitive agreement to acquire Acclara for $675 million and warrants to purchase 12.2 million shares of R1 stock.
Acclara supports patients and providers through streamlined billing and payment processes, improves financial performance and enhances the patient experience. R1 said in December the partnership lays the foundation for the company to “continue to automate revenue management and to extend its scale and diversification to build long-term value for providers, patients and shareholders.”
R1 expects the acquisition and partnership with Providence to contribute more than $625 million in revenue and approximately $185 million to adjusted EBITDA by year five of the partnership, not including potential revenue synergies, according to the release.
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.